Company

FibroBiologics (Nasdaq: FBLG)

Biotechnology Research 16815 Royal Crest Dr 15 employees FBLG

Employees: 15
Contacts: 3
Emails: 3
Phones: 2

www.fibrobiologics.com LinkedIn Crunchbase

FibroBiologics (Nasdaq: FBLG) Overview

Headquarters: 16815 Royal Crest Dr
Website: www.fibrobiologics.com
Industry: Biotechnology Research
Employees: 15
Stock Symbol: FBLG
Funding: 30.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About FibroBiologics (Nasdaq: FBLG)

FibroBiologics (Nasdaq: FBLG) is the world leader in cell therapy using fibroblasts to regenerate tissue and cure chronic diseases. Currently, FibroBiologics holds 150+ U.S. and international issued patents issued/pending across a variety of clinical pathways, including Disc Degeneration, Multiple Sclerosis, and Cancer. FibroBiologics represents the next generation of medical advancement in cell therapy.

FibroBiologics (Nasdaq: FBLG) Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 2; 50.0% coverage

FibroBiologics (Nasdaq: FBLG) Org Chart

Sample employees and titles

Name	Title	Location	Contact
Jinsam Chang	Ph.d Immunology	Katy, Texas, United States	View
Jason Davis	Chief Financial Officer	Greater Houston, United States	Email Phone
Robert E Hoffman	Executive and Board Member	San Diego, California, United States	Email Phone
Phillip Baker	Cell Biology Scientist - Stem Cells	Houston, Texas, United States	Email